Jeil Bio is engaged in research and development of animal pharmaceuticals based on fermentation. It is commercializing the research and development achievements related to product formulation and general feed additive business.
In terms of function and use, animal pharmaceuticals is a general concept that includes therapeutics, preventives, and functional additives. Functional additives serve functions such as digestion promotion, growth promotion, and environmental improvement. Antibiotics are used in large quantities more for growth promotion than for actual therapeutic purposes. In terms of sales scale, the proportion of functional additives is overwhelmingly higher than that of therapeutics or preventives. This is because it is more economical to slaughter livestock animals than to treat them when they fall ill.
Patent attorney Eom Jeonghan of BLT Patent Law Firm reviewed Jeil Bio's patent and trademark application status.
Domestic listed companies disclose patent acquisition facts through the Financial Supervisory Service's electronic disclosure system. However, many stock investors tend to disregard patent disclosures.
Not only patents but also trademark registrations are important indicators for understanding future corporate value, as they foreshadow the direction that listed companies will take. Some patent disclosures even act as direct triggers for stock price increases.
It is not easy for general investors to grasp the impact on companies through patent disclosures or to check trademark application statuses one by one. Asia Economy is reviewing the patent and trademark application status of listed companies together with patent attorney Eom Jeonghan of BLT Patent Law Firm through 'Special Express Train.'
Special Express Train is an abbreviation for a broadcast that diligently searches for stocks soaring due to patents.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
